Skip to content

Water Immersion and Polyp Detection: A Randomized Controlled Trial

Water Immersion and Polyp Detection: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03231917
Enrollment
121
Registered
2017-07-27
Start date
2017-03-01
Completion date
2018-08-31
Last updated
2019-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma, Colonic Neoplasms

Brief summary

We plan to conduct a randomized trial of tandem colonoscopies comparing water infusion and air insufflation for inspection of mucosa on withdrawal. In one randomized group, water infusion will be employed as the first method for mucosal inspection while in a second group, CO2 insufflation will be used first. This study will be different than usual care since the participants will receive two successive or tandem colonoscopies versus one

Interventions

PROCEDUREWater Infusion first

In this group patients will receive a colonoscopy with water infusion for mucosal inspection and then receive a colonoscopy with CO2 insufflation.

PROCEDURECO2 Insufflation First

In this group patients will receive a colonoscopy with CO2 insufflation for mucosal inspection and then receive a colonoscopy with water infusion .

Sponsors

Indiana University
CollaboratorOTHER
White River Junction Veterans Affairs Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
NONE

Intervention model description

In one randomized group, water infusion will be employed as the first method for mucosal inspection while in a second group, CO2 insufflation will be used first. This study will be different than usual care since the participants will receive two successive or tandem colonoscopies versus one

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* all adults 50 years or older who present for colonoscopy at White River Junction VAMC and Indiana University

Exclusion criteria

* includes co-morbid status of ASA III or higher, Inflammatory Bowel Disease (IBD), surgical resection of the large bowel, as well as the use of anticoagulants. Finally, potential subjects who do not report a clear effluent in the most recent bowel movement will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Adenoma Miss RateThrough procedure, an average of 1 hrAdenoma-level miss rates will be calculated as the number of additional adenomas detected during the second examination divided by the total number of adenomas detected during both examinations

Secondary

MeasureTime frameDescription
Patient-level Miss Rate1 hour or the duration of the procedurePatient-level miss rates will be calculated as the number of patients with one or more adenomas detected during the second examination, divided by the total number of patients with at least one adenoma in either examination
Adenoma < 6mm Detection Rate1 hour or the duration of the procedureAdenoma-level miss rates will be calculated as the number of additional adenomas \< 6 mm detected during the second examination divided by the total number of adenomas\< 6 mm detected during both examinations.

Countries

United States

Participant flow

Participants by arm

ArmCount
Water Infusion First
In this group patients will receive a colonoscopy with water infusion for mucosal inspection and then receive a colonoscopy with CO2 insufflation. Water Infusion first: In this group patients will receive a colonoscopy with water infusion for mucosal inspection and then receive a colonoscopy with CO2 insufflation.
60
CO2 Insufflation First
In this group patients will receive a colonoscopy with CO2 insufflation for mucosal inspection and then receive a colonoscopy with water infusion. CO2 Insufflation First: In this group patients will receive a colonoscopy with CO2 insufflation for mucosal inspection and then receive a colonoscopy with water infusion .
61
Total121

Baseline characteristics

CharacteristicWater Infusion FirstCO2 Insufflation FirstTotal
Age, Continuous63.4 years
STANDARD_DEVIATION 7.5
63.4 years
STANDARD_DEVIATION 8.4
63.4 years
STANDARD_DEVIATION 7.8
Colonoscopy ordered for screening purposes?17 Participants21 Participants38 Participants
Monitored anesthesia care (MAC)35 Participants35 Participants70 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
60 participants61 participants121 participants
Sex: Female, Male
Female
16 Participants12 Participants28 Participants
Sex: Female, Male
Male
44 Participants49 Participants93 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 600 / 61
other
Total, other adverse events
0 / 600 / 61
serious
Total, serious adverse events
0 / 600 / 61

Outcome results

Primary

Adenoma Miss Rate

Adenoma-level miss rates will be calculated as the number of additional adenomas detected during the second examination divided by the total number of adenomas detected during both examinations

Time frame: Through procedure, an average of 1 hr

Population: Adenoma miss rate

ArmMeasureValue (NUMBER)
Water Infusion FirstAdenoma Miss Rate52 adenomas missed by first exam
CO2 Insufflation FirstAdenoma Miss Rate37 adenomas missed by first exam
Secondary

Adenoma < 6mm Detection Rate

Adenoma-level miss rates will be calculated as the number of additional adenomas \< 6 mm detected during the second examination divided by the total number of adenomas\< 6 mm detected during both examinations.

Time frame: 1 hour or the duration of the procedure

Population: Adenomas \< 6 mm

ArmMeasureValue (COUNT_OF_UNITS)
Water Infusion FirstAdenoma < 6mm Detection Rate45 Adenomas < 6 mm
CO2 Insufflation FirstAdenoma < 6mm Detection Rate36 Adenomas < 6 mm
p-value: 0.48Chi-squared
Secondary

Patient-level Miss Rate

Patient-level miss rates will be calculated as the number of patients with one or more adenomas detected during the second examination, divided by the total number of patients with at least one adenoma in either examination

Time frame: 1 hour or the duration of the procedure

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Water Infusion FirstPatient-level Miss Rate27 Participants
CO2 Insufflation FirstPatient-level Miss Rate23 Participants

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026